Michel Marty
St. Louis Children's Hospital(US)Washington University in St. Louis(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Nausea and vomiting management, HER2/EGFR in Cancer Research, Venous Thromboembolism Diagnosis and Management, Central Venous Catheters and Hemodialysis
Most-Cited Works
- → Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.(2005)1,597 cited
- → International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer(2012)591 cited
- → Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis(1990)411 cited
- → Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial(2008)370 cited
- → International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer(2012)318 cited